These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

544 related items for PubMed ID: 30335200

  • 1. Zonisamide add-on therapy for focal epilepsy.
    Brigo F, Lattanzi S, Igwe SC, Behzadifar M, Bragazzi NL.
    Cochrane Database Syst Rev; 2018 Oct 18; 10(10):CD001416. PubMed ID: 30335200
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pregabalin add-on for drug-resistant focal epilepsy.
    Panebianco M, Bresnahan R, Marson AG.
    Cochrane Database Syst Rev; 2022 Mar 29; 3(3):CD005612. PubMed ID: 35349176
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Rufinamide add-on therapy for refractory epilepsy.
    Panebianco M, Prabhakar H, Marson AG.
    Cochrane Database Syst Rev; 2018 Apr 25; 4(4):CD011772. PubMed ID: 29691835
    [Abstract] [Full Text] [Related]

  • 9. Lamotrigine add-on therapy for drug-resistant focal epilepsy.
    Panebianco M, Bresnahan R, Ramaratnam S, Marson AG.
    Cochrane Database Syst Rev; 2020 Mar 20; 3(3):CD001909. PubMed ID: 32196639
    [Abstract] [Full Text] [Related]

  • 10. Lacosamide add-on therapy for focal epilepsy.
    Babar RK, Bresnahan R, Gillespie CS, Michael BD.
    Cochrane Database Syst Rev; 2021 May 17; 5(5):CD008841. PubMed ID: 33998660
    [Abstract] [Full Text] [Related]

  • 11. Eslicarbazepine acetate add-on therapy for drug-resistant focal epilepsy.
    Chang XC, Yuan H, Wang Y, Xu HQ, Hong WK, Zheng RY.
    Cochrane Database Syst Rev; 2021 Jun 22; 6(6):CD008907. PubMed ID: 34155624
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Zonisamide add-on for drug-resistant partial epilepsy.
    Chadwick DW, Marson AG.
    Cochrane Database Syst Rev; 2005 Oct 19; (4):CD001416. PubMed ID: 16235282
    [Abstract] [Full Text] [Related]

  • 14. Levetiracetam add-on for drug-resistant focal epilepsy: an updated Cochrane Review.
    Mbizvo GK, Dixon P, Hutton JL, Marson AG.
    Cochrane Database Syst Rev; 2012 Sep 12; 2012(9):CD001901. PubMed ID: 22972056
    [Abstract] [Full Text] [Related]

  • 15. Oxcarbazepine add-on for drug-resistant focal epilepsy.
    Bresnahan R, Atim-Oluk M, Marson AG.
    Cochrane Database Syst Rev; 2020 Mar 04; 3(3):CD012433. PubMed ID: 32129501
    [Abstract] [Full Text] [Related]

  • 16. Topiramate add-on for drug-resistant partial epilepsy.
    Pulman J, Jette N, Dykeman J, Hemming K, Hutton JL, Marson AG.
    Cochrane Database Syst Rev; 2014 Feb 25; (2):CD001417. PubMed ID: 24570033
    [Abstract] [Full Text] [Related]

  • 17. Cenobamate add-on therapy for drug-resistant focal epilepsy.
    Brigo F, Lattanzi S.
    Cochrane Database Syst Rev; 2024 Aug 01; 8(8):CD014941. PubMed ID: 39087564
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Brivaracetam add-on therapy for drug-resistant epilepsy.
    Bresnahan R, Panebianco M, Marson AG.
    Cochrane Database Syst Rev; 2022 Mar 14; 3(3):CD011501. PubMed ID: 35285519
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.